Nicosia, Cyprus – August, 2024 — Embio Diagnostics is proud to announce the latest advancements in its airbeld diagnostic technology, aimed at enhancing children’s health and well-being. Leveraging cutting-edge research and innovative methodologies, Embio Diagnostics is committed to providing accurate, rapid, and reliable diagnostic solutions.

• Ιnnovative Technology: Embio Diagnostics employs state-of-the-art technology to ensure precise and timely diagnostic results, critical for early intervention and effective treatment in pediatric healthcare.
• Research and Development: Continuous investment in R&D enables Embio Diagnostics to stay at the forefront of medical advancements, contributing significantly to public health.
• Community Engagement: Active participation in community initiatives, such as the recent collaboration with Children First CY, underscores Embio Diagnostics’ commitment to social responsibility and children’s health.

Dr. Konstantinos Makris, a leading collaborator at Embio Diagnostics, emphasizes the importance of innovation in diagnostics: “Our mission is to transform the landscape of pediatric healthcare by providing tools that allow for early and accurate detection of health issues, ultimately leading to better health outcomes for children.”

About Embio Diagnostics
Embio Diagnostics is a leader in biotechnology, specializing in the development of advanced diagnostic solutions. With a focus on accuracy, speed, and reliability, Embio Diagnostics serves a critical role in healthcare, ensuring that patients receive the best possible care.

For more information, please visit www.embiodiagnostics.eu or contact us at info@embiodiagnostics.eu.

For Media Inquiries:

Stephanie Constantinidou

Marketing Officer

EMBIO Diagnostics

Nicosia, Cyprus

s.constantinidou@embiodiagnostics.eu